{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-22-000062","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.076271+00:00","generated_at":"2026-06-21T12:00:38.671751+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aspira Women's Health appoints Marlene McLennan as interim CFO effective Dec 1, 2022","bullets":["Marlene McLennan appointed interim CFO, effective December 1, 2022; prior CFO at Vestige Healthcare and other healthcare firms.","Annual base salary of $350,400; eligible for bonus up to 50% of base subject to board approval.","Stock option grants of 25,000 shares per 6-month term under 2019 Stock Incentive Plan.","Severance lump sum of $60,000 if terminated without cause or non-renewal, subject to performance criteria.","Employment agreement initial 6-month term, renewable up to 18 months total."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-22-000062","json":"https://secwatch.observer/filing/0000926617-22-000062.json","markdown":"https://secwatch.observer/filing/0000926617-22-000062.md","text":"https://secwatch.observer/filing/0000926617-22-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/0000926617-22-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/awh-20221128x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:00:38.671751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fbe1b6105","claim":"Marlene McLennan was appointed as interim Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Marlene McLennan as the Company’s interim Chief Financial Officer, effective as of December 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/0000926617-22-000062-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}